97 related articles for article (PubMed ID: 33605788)
1. End-of-life cost for lung cancer patients in Greece: a hospital-based retrospective study.
Kokkotou E; Stefanou G; Syrigos N; Gourzoulidis G; Ntalakou E; Apostolopoulou A; Charpidou A; Kourlaba G
J Comp Eff Res; 2021 Mar; 10(4):315-324. PubMed ID: 33605788
[No Abstract] [Full Text] [Related]
2. The economic burden of end-of-life care in metastatic breast cancer.
Bramley T; Antao V; Lunacsek O; Hennenfent K; Masaquel A
J Med Econ; 2016 Nov; 19(11):1075-1080. PubMed ID: 27248201
[TBL] [Abstract][Full Text] [Related]
3. Impact of Targeted Therapy on the Quality of End-of-Life Care for Patients With Non-Small-Cell Lung Cancer: A Population-Based Study in Taiwan.
Tsai HY; Chung KP; Kuo RN
J Pain Symptom Manage; 2018 Mar; 55(3):798-807.e4. PubMed ID: 29056563
[TBL] [Abstract][Full Text] [Related]
4. Medical care costs at the end of life among older adults with cancer: a national health insurance data-based cohort study.
Jo M; Lee Y; Kim T
BMC Palliat Care; 2023 Jun; 22(1):76. PubMed ID: 37349710
[TBL] [Abstract][Full Text] [Related]
5. Concurrent Hospice Care and Cancer-Directed Treatment for Advanced Lung Cancer and Receipt of Aggressive Care at the End of Life in the Veteran's Health Administration.
Presley CJ; Han L; O'Leary JR; Zhu W; Corneau E; Chao H; Shamas T; Rose M; Lorenz K; Levy CR; Mor V; Gross CP
J Palliat Med; 2020 Aug; 23(8):1038-1044. PubMed ID: 32119800
[No Abstract] [Full Text] [Related]
6. Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States.
Haque W; Verma V; Butler EB; Teh BS
Anticancer Res; 2019 Jun; 39(6):3137-3140. PubMed ID: 31177159
[TBL] [Abstract][Full Text] [Related]
7. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
[TBL] [Abstract][Full Text] [Related]
8. Dying with cancer: patients' function, symptoms, and care preferences as death approaches.
McCarthy EP; Phillips RS; Zhong Z; Drews RE; Lynn J
J Am Geriatr Soc; 2000 May; 48(S1):S110-21. PubMed ID: 10809464
[TBL] [Abstract][Full Text] [Related]
9. The annual direct costs of stable COPD in Greece.
Stafyla E; Geitona M; Kerenidi T; Economou A; Daniil Z; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2018; 13():309-315. PubMed ID: 29398912
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of the pattern of terminal care and hospital death in patients with non-small cell lung cancer.
Nieder C; Tollåli T; Norum J; Pawinski A; Bremnes RM
Anticancer Res; 2012 Jan; 32(1):189-94. PubMed ID: 22213306
[TBL] [Abstract][Full Text] [Related]
11. Utilization of palliative care resource remains low, consuming potentially avoidable hospital admissions in stage IV non-small cell lung cancer: a community-based retrospective review.
Meggyesy AM; Buehler KE; Wilshire CL; Chiu ST; Chang SC; Rayburn JR; Gilbert CR; Gorden JA
Support Care Cancer; 2022 Dec; 30(12):10117-10126. PubMed ID: 36374328
[TBL] [Abstract][Full Text] [Related]
12. End-of-life cost and its determinants for cancer patients in urban China: a population-based retrospective study.
Li Z; Pan Z; Zhang L; He R; Jiang S; Xu C; Lu F; Zhang P; Li B
BMJ Open; 2019 Mar; 9(3):e026309. PubMed ID: 30898830
[TBL] [Abstract][Full Text] [Related]
13. End-of-Life Health-Care Cost of Patients With Lung Cancer: A Retrospective Study.
Souliotis K; Kani C; Marioli A; Kamboukou A; Prinou A; Syrigos K; Markantonis S
Health Serv Res Manag Epidemiol; 2019; 6():2333392819841223. PubMed ID: 31008147
[TBL] [Abstract][Full Text] [Related]
14. Medical costs of Japanese lung cancer patients during end-of-life care.
Awano N; Izumo T; Inomata M; Kuse N; Tone M; Takada K; Muto Y; Fujimoto K; Kimura H; Miyamoto S; Igarashi A; Kunitoh H
Jpn J Clin Oncol; 2021 Apr; 51(5):769-777. PubMed ID: 33506245
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer patients' journey from first symptom to treatment: Results from a Greek registry.
Kourlaba G; Gkiozos I; Kokkotou E; Stefanou G; Papaspiliou A; Syrigos K
Cancer Epidemiol; 2019 Jun; 60():193-200. PubMed ID: 31063908
[TBL] [Abstract][Full Text] [Related]
16. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.
Bremner KE; Krahn MD; Warren JL; Hoch JS; Barrett MJ; Liu N; Barbera L; Yabroff KR
Palliat Med; 2015 Dec; 29(10):918-28. PubMed ID: 26330452
[TBL] [Abstract][Full Text] [Related]
17. Resource use in the last three months of life by lung cancer patients in southern Ontario.
Wang Y; Van Dam A; Slaven M; Ellis KJ; Goffin JR; Juergens RA; Ellis PM
Curr Oncol; 2019 Aug; 26(4):247-252. PubMed ID: 31548804
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis and estimation of thoracic surgical patients with lung cancer in Greece: the case of Sotiria ICU.
Leftakis A; Geitona M
Intensive Crit Care Nurs; 2001 Dec; 17(6):322-30. PubMed ID: 11853008
[TBL] [Abstract][Full Text] [Related]
19. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
20. End-of-life intravenous chemotherapy administration patterns in the treatment of Queensland lung and pancreas cancer patients: a 10-year retrospective analysis.
Allen MJ; Dunn N; Guan T; Harrington J; Walpole E
Intern Med J; 2022 Apr; 52(4):623-632. PubMed ID: 33070428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
